1. Home
  2. SYBT vs SRPT Comparison

SYBT vs SRPT Comparison

Compare SYBT & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stock Yards Bancorp Inc.

SYBT

Stock Yards Bancorp Inc.

HOLD

Current Price

$79.97

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

SELL

Current Price

$17.99

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SYBT
SRPT
Founded
1904
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2009
2000

Fundamental Metrics

Financial Performance
Metric
SYBT
SRPT
Price
$79.97
$17.99
Analyst Decision
Hold
Hold
Analyst Count
6
24
Target Price
★ $87.60
$21.64
AVG Volume (30 Days)
134.9K
★ 2.5M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 1.62%
N/A
EPS Growth
★ 22.11
N/A
EPS
2.55
★ 2.99
Revenue
$23,406,000.00
★ $2,198,237,000.00
Revenue This Year
$15.69
N/A
Revenue Next Year
$9.90
N/A
P/E Ratio
$31.97
★ $6.35
Revenue Growth
3.37
★ 15.58
52 Week Low
$61.51
$14.68
52 Week High
$89.22
$24.68

Technical Indicators

Market Signals
Indicator
SYBT
SRPT
Relative Strength Index (RSI) 61.70 53.59
Support Level $75.81 $18.38
Resistance Level $82.14 $19.71
Average True Range (ATR) 1.75 0.91
MACD 0.53 0.13
Stochastic Oscillator 74.85 75.22

Price Performance

Historical Comparison
SYBT
SRPT

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: